The results showed that at the end of the treatment, 97.22% of individuals demonstrated an increase in telomere length with an average increase of 0.43 Kbp. Furthermore, 94.44% of participants exhibited reduced biological age with an average decrease of 3.8 years. These improvements were statistically significant and indicative of a positive effect on aging symptoms.